tiprankstipranks
AbCellera Biologics (ABCL)
NASDAQ:ABCL
Holding ABCL?
Track your performance easily

AbCellera Biologics (ABCL) Financial Statements

1,575 Followers

AbCellera Biologics Financial Overview

AbCellera Biologics's market cap is currently ―. The company's EPS TTM is $-0.6; its P/E ratio is -4.45; AbCellera Biologics is scheduled to report earnings on February 25, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 7.32M$ 9.95M$ 9.18M$ 6.60M$ 10.06M
Gross Profit$ 7.32M$ 9.95M$ 9.18M$ 6.60M$ 10.06M
EBIT$ -48.19M$ -42.75M$ -48.60M$ -39.28M$ -34.06M
EBITDA$ -10.15M$ -35.98M$ -39.49M$ -31.87M$ -26.81M
Net Income Common Stockholders$ -36.93M$ -40.61M$ -47.15M$ -28.61M$ -26.59M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 670.36M$ 698.02M$ 760.59M$ 785.84M$ 795.69M
Total Assets$ 1.41B$ 1.46B$ 1.49B$ 1.51B$ 1.54B
Total Debt$ 79.46M$ 81.21M$ 84.49M$ 80.76M$ 84.03M
Net Debt$ -590.89M$ -616.81M$ -676.09M$ -705.08M$ -711.66M
Total Liabilities$ 301.51M$ 333.18M$ 285.30M$ 275.49M$ 342.34M
Stockholders Equity$ 1.11B$ 1.13B$ 1.15B$ 1.18B$ 1.19B
Cash Flow-
Free Cash Flow$ -50.08M$ -65.85M$ -34.04M$ -21.00M$ -7.30M
Operating Cash Flow$ -29.97M$ -41.71M$ -19.61M$ -106.00K$ 19.90M
Investing Cash Flow$ 52.10M$ 29.91M$ -24.32M$ -12.79M$ -34.39M
Financing Cash Flow$ 2.65M$ 2.83M$ 3.77M$ 6.63M$ 419.00K
Currency in USD

AbCellera Biologics Earnings and Revenue History

AbCellera Biologics Debt to Assets

AbCellera Biologics Cash Flow

AbCellera Biologics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis